US Stock MarketDetailed Quotes
AMIX Autonomix Medical
- 0.625
- +0.003+0.55%
Close Aug 16 16:00 ET
- 0.625
- 0.0000.00%
Post 19:59 ET
14.40MMarket Cap-696P/E (TTM)
0.638High0.610Low126.23KVolume0.622Open0.622Pre Close79.10KTurnover0.98%Turnover RatioLossP/E (Static)23.04MShares7.60052wk High2.72P/B8.05MFloat Cap0.51052wk Low--Dividend TTM12.88MShs Float7.600Historical High--Div YieldTTM4.50%Amplitude0.510Historical Low0.626Avg Price1Lot Size
Autonomix Medical Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||
| Gross profit | ||||||||
| Operating expense | 216.07%2.75M | 275.58%7.47M | 267.73%2.42M | 437.50%2.92M | 871K | 1.99M | 657K | 544K |
| Selling and administrative expenses | 257.65%1.8M | 321.61%5.25M | 530.00%1.58M | 573.33%2.32M | --503K | --1.25M | --250K | --345K |
| -General and administrative expense | 257.65%1.8M | 321.61%5.25M | 530.00%1.58M | 573.33%2.32M | --503K | --1.25M | --250K | --345K |
| Research and development costs | 159.24%954K | 198.66%2.23M | 106.63%841K | 202.01%601K | --368K | --745K | --407K | --199K |
| Operating profit | -216.07%-2.75M | -275.58%-7.47M | -267.73%-2.42M | -437.50%-2.92M | -871K | -1.99M | -657K | -544K |
| Net non-operating interest income expense | 800.00%54K | 48K | 34K | -10K | 6K | 0 | 0 | 0 |
| Non-operating interest income | 1,483.33%95K | --127K | --80K | --23K | --6K | --0 | --0 | --0 |
| Non-operating interest expense | --41K | --79K | --46K | --33K | --0 | --0 | --0 | --0 |
| Other net income (expense) | -8M | -3.03M | -179K | |||||
| Gain on sale of security | ---- | ---8M | ---3.03M | ---179K | ---- | ---- | ---- | ---- |
| Income before tax | -212.02%-2.7M | -675.18%-15.43M | -723.14%-5.41M | -472.24%-3.11M | -865K | -1.99M | -657K | -544K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -212.02%-2.7M | -675.18%-15.43M | -723.14%-5.41M | -472.24%-3.11M | -865K | -1.99M | -657K | -544K |
| Net income continuous Operations | -212.02%-2.7M | -675.18%-15.43M | -723.14%-5.41M | -472.24%-3.11M | ---865K | ---1.99M | ---657K | ---544K |
| Minority interest income | ||||||||
| Net income attributable to the parent company | -212.02%-2.7M | -675.18%-15.43M | -723.14%-5.41M | -472.24%-3.11M | -865K | -1.99M | -657K | -544K |
| Preferred stock dividends | ||||||||
| Other preferred stock dividends | ||||||||
| Net income attributable to common stockholders | -212.02%-2.7M | -675.18%-15.43M | -723.14%-5.41M | -472.24%-3.11M | -865K | -1.99M | -657K | -544K |
| Basic earnings per share | -241.79%-0.14 | -1,014.26%-1.05 | -822.36%-0.287 | -472.25%-0.1474 | -0.041 | -0.0942 | -0.0311 | -0.0258 |
| Diluted earnings per share | -241.79%-0.14 | -1,014.26%-1.05 | -822.36%-0.287 | -472.25%-0.1474 | -0.041 | -0.0942 | -0.0311 | -0.0258 |
| Dividend per share | ||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg